Cargando…
Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients
BACKGROUND: Analysis of circulating free DNA (cfDNA) is a promising tool for personalized management of colorectal cancer (CRC) patients. Untargeted cfDNA analysis using whole-genome sequencing (WGS) does not need a priori knowledge of the patient´s mutation profile. METHODS: Here we established LIq...
Autores principales: | Hallermayr, Ariane, Wohlfrom, Tobias, Steinke-Lange, Verena, Benet-Pagès, Anna, Scharf, Florentine, Heitzer, Ellen, Mansmann, Ulrich, Haberl, Christopher, de Wit, Maike, Vogelsang, Holger, Rentsch, Markus, Holinski-Feder, Elke, Pickl, Julia M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438339/ https://www.ncbi.nlm.nih.gov/pubmed/36056434 http://dx.doi.org/10.1186/s13045-022-01342-z |
Ejemplares similares
-
Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management
por: Hallermayr, Ariane, et al.
Publicado: (2022) -
Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants
por: Hallermayr, Ariane, et al.
Publicado: (2022) -
Extending the critical regions for mutations in the non‐coding gene RNU4ATAC in another patient with Roifman Syndrome
por: Hallermayr, Ariane, et al.
Publicado: (2018) -
Critical assessment of secondary findings in genes linked to primary arrhythmia syndromes
por: Diebold, Isabel, et al.
Publicado: (2020) -
Mitochondrial and nuclear disease panel (Mito‐aND‐Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost‐effective and sensitive NGS‐based method
por: Abicht, Angela, et al.
Publicado: (2018)